Eniko Schreiner

Title: Eniko Schreiner: Innovator in Antibacterial Compounds

Introduction

Eniko Schreiner is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. With a total of 3 patents to her name, her work is recognized for its innovative approach to addressing bacterial infections.

Latest Patents

Eniko's latest patents focus on the preparation of pseudo-primycin complexes. The first patent describes a process for the preparation of antibacterial pseudo-primycin complexes of a specific formula. This invention relates to the components and acid addition salts of these complexes, as well as the pharmaceutical compositions that contain them as active ingredients. The formula includes various components where R.sup.1 can be butyl, pentyl, or hexyl, R.sup.2 can be hydrogen, hydroxyl, or O-arabinose, and X represents an organic or inorganic acid ion.

The second patent reiterates the same focus on pseudo-primycin complexes, emphasizing their antibacterial properties and the preparation methods involved. This work is crucial in the ongoing fight against bacterial infections and showcases Eniko's dedication to advancing medical science.

Career Highlights

Eniko Schreiner is currently employed at Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a company known for its pharmaceutical innovations. Her role at this organization allows her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical research.

Collaborations

Eniko has worked alongside notable colleagues such as Istvan Pelczer and Gabor Kulcsar. These collaborations have played a vital role in her research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Eniko Schreiner's work in the field of antibacterial compounds highlights her significant contributions to pharmaceutical science. Her innovative patents and collaborations with esteemed colleagues underscore her commitment to improving healthcare through research and development.